All In Biotech

Drug Trial Radar · NCT00944424

Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca

GORG - 002 Randomized Phase III Trial to Determine the Effectiveness of High Dose Versus Standard Dose of Vitamin D2 (Ergocalciferol) Given With Docetaxel in Patients With Metastatic Breast Cancer

Last checked: Nov 20, 2026Latest source record: Dec 13, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknownPivotal-lookingPhase 3. Randomized with 260 participants. This is a heuristic, not a regulatory label.

Status

Status unknown

Enrollment

260

Planned (sponsor's estimate)

Start

Jul 2009

Primary completion

Jul 2012

Study completion Jul 2012

Sponsor

Lead sponsor
King Faisal Specialist Hospital & Research CenterAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 23, 2009

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Single (investigator)
Primary purpose
Treatment
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Randomized phase III trial to determine the effectiveness of High dose versus Standard dose of Vitamin D2 (Ergocalciferol) given with Docetaxel in patients with metastatic breast cancer

Conditions

  • Breast Cancer

Interventions

  • Docetaxel + High dose Vitamin D2Drug

    Docetaxel + High dose Vitamin D2

  • Docetaxel + Standard dose Vitamin D2Drug

    Docetaxel + Standard dose Vitamin D2

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Time to progression is from the start of Docetaxel to disease progression. Patients who have not progressed at the time of study completion or who are lost to follow-up are censored at the last Vitamin D administration date.Time frame: 1 year

Locations

6 sites in 3 countries. Site status is shown where the registry gives one.

  • Kuwait Cancer Center

    Kuwait City, Kuwait · Not yet recruiting

  • King Abdulaziz Hospital and Oncology Center

    Jeddah, Saudi Arabia · Not yet recruiting

  • King Abdulaziz Medical City

    Riyadh, Saudi Arabia · Not yet recruiting

  • King Fahad Medical City

    Riyadh, Saudi Arabia · Not yet recruiting

  • King Faisal Specialist Hospital & Research Center

    Riyadh, Central, Saudi Arabia · Recruiting

  • Tawam Hospital

    Al Ain City, United Arab Emirates · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.